Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
162.30
+2.62 (1.64%)
At close: Feb 21, 2025, 4:00 PM
162.40
+0.10 (0.06%)
After-hours: Feb 21, 2025, 7:33 PM EST
Johnson & Johnson Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2020 - 2016 |
Revenue | 88,821 | 85,159 | 79,990 | 78,740 | 82,584 | Upgrade
|
Revenue Growth (YoY) | 4.30% | 6.46% | 1.59% | -4.65% | 0.64% | Upgrade
|
Cost of Revenue | 27,436 | 26,244 | 24,596 | 23,402 | 28,427 | Upgrade
|
Gross Profit | 61,385 | 58,915 | 55,394 | 55,338 | 54,157 | Upgrade
|
Selling, General & Admin | 21,952 | 20,166 | 19,078 | 19,506 | 21,731 | Upgrade
|
Research & Development | 17,232 | 15,085 | 14,135 | 14,277 | 12,159 | Upgrade
|
Operating Expenses | 39,184 | 35,251 | 33,213 | 33,783 | 33,890 | Upgrade
|
Operating Income | 22,201 | 23,664 | 22,181 | 21,555 | 20,267 | Upgrade
|
Interest Expense | -755 | -772 | -276 | -183 | -201 | Upgrade
|
Interest & Investment Income | 1,332 | 1,261 | 490 | 53 | 111 | Upgrade
|
Currency Exchange Gain (Loss) | -214 | -366 | -286 | -216 | -209 | Upgrade
|
Other Non Operating Income (Expenses) | 1,482 | 1,764 | -556 | -550 | -2,922 | Upgrade
|
EBT Excluding Unusual Items | 24,046 | 25,551 | 21,553 | 20,659 | 17,046 | Upgrade
|
Merger & Restructuring Charges | -1,069 | -1,098 | -575 | -209 | -247 | Upgrade
|
Gain (Loss) on Sale of Investments | -300 | -600 | - | - | 1 | Upgrade
|
Gain (Loss) on Sale of Assets | 226 | 117 | 380 | 617 | 111 | Upgrade
|
Asset Writedown | -405 | -1,295 | -1,216 | -989 | -233 | Upgrade
|
Legal Settlements | -5,500 | -6,900 | - | - | - | Upgrade
|
Other Unusual Items | -100 | -400 | - | - | - | Upgrade
|
Pretax Income | 16,687 | 15,062 | 19,359 | 19,178 | 16,497 | Upgrade
|
Income Tax Expense | 2,621 | 1,736 | 2,989 | 1,377 | 1,783 | Upgrade
|
Earnings From Continuing Operations | 14,066 | 13,326 | 16,370 | 17,801 | 14,714 | Upgrade
|
Earnings From Discontinued Operations | - | 21,827 | 1,571 | 3,077 | - | Upgrade
|
Net Income | 14,066 | 35,153 | 17,941 | 20,878 | 14,714 | Upgrade
|
Net Income to Common | 14,066 | 35,153 | 17,941 | 20,878 | 14,714 | Upgrade
|
Net Income Growth | -59.99% | 95.94% | -14.07% | 41.89% | -2.68% | Upgrade
|
Shares Outstanding (Basic) | 2,407 | 2,534 | 2,625 | 2,632 | 2,633 | Upgrade
|
Shares Outstanding (Diluted) | 2,429 | 2,560 | 2,664 | 2,674 | 2,671 | Upgrade
|
Shares Change (YoY) | -5.12% | -3.89% | -0.38% | 0.12% | -0.51% | Upgrade
|
EPS (Basic) | 5.84 | 13.88 | 6.83 | 7.93 | 5.59 | Upgrade
|
EPS (Diluted) | 5.79 | 13.72 | 6.73 | 7.81 | 5.51 | Upgrade
|
EPS Growth | -57.81% | 103.94% | -13.84% | 41.76% | -2.13% | Upgrade
|
Free Cash Flow | 18,059 | 17,778 | 17,185 | 19,758 | 20,189 | Upgrade
|
Free Cash Flow Per Share | 7.43 | 6.94 | 6.45 | 7.39 | 7.56 | Upgrade
|
Dividend Per Share | 4.910 | 4.700 | 4.450 | 4.190 | 3.980 | Upgrade
|
Dividend Growth | 4.47% | 5.62% | 6.21% | 5.28% | 6.13% | Upgrade
|
Gross Margin | 69.11% | 69.18% | 69.25% | 70.28% | 65.58% | Upgrade
|
Operating Margin | 25.00% | 27.79% | 27.73% | 27.37% | 24.54% | Upgrade
|
Profit Margin | 15.84% | 41.28% | 22.43% | 26.52% | 17.82% | Upgrade
|
Free Cash Flow Margin | 20.33% | 20.88% | 21.48% | 25.09% | 24.45% | Upgrade
|
EBITDA | 29,540 | 30,767 | 28,510 | 28,206 | 27,498 | Upgrade
|
EBITDA Margin | 33.26% | 36.13% | 35.64% | 35.82% | 33.30% | Upgrade
|
D&A For EBITDA | 7,339 | 7,103 | 6,329 | 6,651 | 7,231 | Upgrade
|
EBIT | 22,201 | 23,664 | 22,181 | 21,555 | 20,267 | Upgrade
|
EBIT Margin | 25.00% | 27.79% | 27.73% | 27.37% | 24.54% | Upgrade
|
Effective Tax Rate | 15.71% | 11.53% | 15.44% | 7.18% | 10.81% | Upgrade
|
Advertising Expenses | 600 | 500 | 700 | 1,200 | 2,100 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.